Cytoplasmic FKBP7 reflux sustains NFE2L1 levels in an adaptive response to chemotherapy in prostate cancer cells
Luce Dreno, Farès Ousalem, Anilo Albornoz-Loaiza, Besime CELIK, Carolina Tiraboschi, Giuseppina Claps, Nader Al-Nakouzi, Daniel Compagno, Thibault Dayris, Marine Aglave, Yohann Loriot, Nadine Assrir, Ewen Lescop, Anne Chauchereau
This paper identifies FKBP7's role in sustaining NFE2L1 levels to promote chemoresistance in prostate cancer cells through cytoplasmic translational control.
bioRxiv · Oct 14, 2026 · PreprintCancer Biology